<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Diard M</submitter><funding>Swiss National Science Foundation</funding><funding>European Research Council</funding><funding>NIAID NIH HHS</funding><pagination>830-841</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7611113</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(7)</volume><pubmed_abstract>The ability of gut bacterial pathogens to escape immunity by antigenic variation-particularly via changes to surface-exposed antigens-is a major barrier to immune clearance&lt;sup>1&lt;/sup>. However, not all variants are equally fit in all environments&lt;sup>2,3&lt;/sup>. It should therefore be possible to exploit such immune escape mechanisms to direct an evolutionary trade-off. Here, we demonstrate this phenomenon using Salmonella enterica subspecies enterica serovar Typhimurium (S.Tm). A dominant surface antigen of S.Tm is its O-antigen: a long, repetitive glycan that can be rapidly varied by mutations in biosynthetic pathways or by phase variation&lt;sup>4,5&lt;/sup>. We quantified the selective advantage of O-antigen variants in the presence and absence of O-antigen-specific immunoglobulin A and iden</pubmed_abstract><journal>Nature microbiology</journal><pubmed_title>A rationally designed oral vaccine induces immunoglobulin A in the murine gut that directs the evolution of attenuated Salmonella variants.</pubmed_title><pmcid>PMC7611113</pmcid><funding_grant_id>200020</funding_grant_id><funding_grant_id>185128</funding_grant_id><funding_grant_id>192567</funding_grant_id><funding_grant_id>R01 AI041239</funding_grant_id><funding_grant_id>176954</funding_grant_id><funding_grant_id>173338</funding_grant_id><funding_grant_id>180953</funding_grant_id><funding_grant_id>159707</funding_grant_id><funding_grant_id>310030</funding_grant_id><funding_grant_id>865730</funding_grant_id><pubmed_authors>Hockenberry A</pubmed_authors><pubmed_authors>Lentsch V</pubmed_authors><pubmed_authors>van der Woude MW</pubmed_authors><pubmed_authors>Meier BH</pubmed_authors><pubmed_authors>Hardt WD</pubmed_authors><pubmed_authors>Viollier PH</pubmed_authors><pubmed_authors>Schumann-Moor K</pubmed_authors><pubmed_authors>Adamcik J</pubmed_authors><pubmed_authors>Arnoldini M</pubmed_authors><pubmed_authors>Bonfiglio F</pubmed_authors><pubmed_authors>Diard M</pubmed_authors><pubmed_authors>Aslani S</pubmed_authors><pubmed_authors>Mezzenga R</pubmed_authors><pubmed_authors>Hoces D</pubmed_authors><pubmed_authors>Slack E</pubmed_authors><pubmed_authors>Rocker A</pubmed_authors><pubmed_authors>Holst O</pubmed_authors><pubmed_authors>Donohue N</pubmed_authors><pubmed_authors>Falquet L</pubmed_authors><pubmed_authors>Loverdo C</pubmed_authors><pubmed_authors>Zandomeneghi G</pubmed_authors><pubmed_authors>Stadtmueller BM</pubmed_authors><pubmed_authors>Bekele NA</pubmed_authors><pubmed_authors>Bohi F</pubmed_authors><pubmed_authors>Wuthrich D</pubmed_authors><pubmed_authors>Piccoli L</pubmed_authors><pubmed_authors>Lanzavecchia A</pubmed_authors><pubmed_authors>Egli A</pubmed_authors><pubmed_authors>Bakkeren E</pubmed_authors></additional><is_claimable>false</is_claimable><name>A rationally designed oral vaccine induces immunoglobulin A in the murine gut that directs the evolution of attenuated Salmonella variants.</name><description>The ability of gut bacterial pathogens to escape immunity by antigenic variation-particularly via changes to surface-exposed antigens-is a major barrier to immune clearance&lt;sup>1&lt;/sup>. However, not all variants are equally fit in all environments&lt;sup>2,3&lt;/sup>. It should therefore be possible to exploit such immune escape mechanisms to direct an evolutionary trade-off. Here, we demonstrate this phenomenon using Salmonella enterica subspecies enterica serovar Typhimurium (S.Tm). A dominant surface antigen of S.Tm is its O-antigen: a long, repetitive glycan that can be rapidly varied by mutations in biosynthetic pathways or by phase variation&lt;sup>4,5&lt;/sup>. We quantified the selective advantage of O-antigen variants in the presence and absence of O-antigen-specific immunoglobulin A and iden</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-05-08T04:36:10.641Z</modification><creation>2022-02-11T13:10:37.327Z</creation></dates><accession>S-EPMC7611113</accession><cross_references><pubmed>34045711</pubmed><doi>10.1038/s41564-021-00911-1</doi></cross_references></HashMap>